Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Shortage reports
Actual shortage:
20 (3%)
Anticipated shortage:
6 (1%)
Avoided shortage:
88 (12%)
Resolved:
604 (84%)
718
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
235 (100%)
Reversed:
0 (0%)
235
89 (9%)
19 (73%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-03-17 | 2021-05-19 | 135797 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2017-10-26 | 2018-08-23 | 27093 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2023-01-17 | 2023-02-02 | 181311 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2019-10-01 | 2020-01-13 | 95097 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-01-05 | 2021-01-21 | 130872 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2017-05-19 | 2019-03-09 | 10718 |
| LABETALOL HYDROCHLORIDE INJECTION, USP | 5MG | SOLUTION | Resolved | 2019-03-13 | 2024-12-10 | 78454 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2022-06-09 | 2022-07-12 | 162343 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-05-14 | 2019-08-31 | 84070 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-03-25 | 2020-04-29 | 109369 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2021-12-21 | 2022-01-04 | 151687 |
| MOVISSE | 0.35MG | TABLET | Avoided shortage | 2017-10-18 | 2018-02-09 | 26211 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-01-29 | 2020-02-26 | 104691 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2019-08-07 | 2020-01-23 | 91044 |
| MYL-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-01-06 | 2021-02-04 | 130906 |
| MYL-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2025-01-21 | 2025-03-03 | 248183 |
| MYL-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23160 |
| MYL-PROPAFENONE | 300MG | TABLET | Resolved | 2017-09-22 | 2018-03-02 | 23163 |
| MYL-SILDENAFIL | 100MG | TABLET | Avoided shortage | 2017-04-13 | 2017-07-17 | 6976 |
| MYL-SILDENAFIL | 50MG | TABLET | Resolved | 2017-04-04 | 2018-08-23 | 5307 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-OLANZAPINE | 5MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53775 |
| MYLAN-OLANZAPINE | 2.5MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53770 |
| MYLAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16009 |
| MYLAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16012 |
| MYLAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16015 |
| MYLAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16018 |
| MYLAN-OMEPRAZOLE | 10MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2018-06-12 | 2018-08-28 | 52267 |
| MYLAN-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2018-05-04 | 2018-05-04 | 48569 |
| MYLAN-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-06-05 | 2018-07-04 | 51513 |
| MYLAN-PAROXETINE | 10MG | TABLET | Discontinued | 2018-06-05 | 2018-07-04 | 51523 |
| MYLAN-PAROXETINE | 20MG | TABLET | Discontinued | 2018-06-05 | 2018-07-04 | 51529 |
| MYLAN-PAROXETINE | 30MG | TABLET | Discontinued | 2018-06-05 | 2018-07-04 | 51535 |
| MYLAN-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-06-05 | 2018-07-04 | 51554 |
| MYLAN-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-06-05 | 2018-07-04 | 51551 |
| MYLAN-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-06-05 | 2018-07-04 | 51548 |
| MYLAN-PRAMIPEXOLE | 0.25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6710 |
| MYLAN-PRAMIPEXOLE | 0.5MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6714 |
| MYLAN-PRAMIPEXOLE | 1MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6717 |
| MYLAN-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6720 |
| MYLAN-PRAVASTATIN | 10MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16029 |